A Study of Probiotics Administration in the Immunotherapy of Urothelial Bladder Carcinoma

NCT05220124 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

190

Enrollment

OTHER

Sponsor class

Conditions

Bladder Urothelial Carcinoma

Interventions

DRUG: Live Combined (Bifidobacterium,Lactobacillus and Enterococcus Capsules)

Sponsor

Tianjin Medical University Second Hospital